Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Cancer Care Center, Incorporated
mi
from
Salem, OH
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Cancer Care Center, Incorporated
mi
from
Salem, OH
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Cancer Treatment Center
mi
from
Wooster, OH
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Cancer Treatment Center
mi
from
Wooster, OH
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
McLeod Regional Medical Center
mi
from
Florence, SC
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
McLeod Regional Medical Center
mi
from
Florence, SC
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
CCOP - Greenville
mi
from
Greenville, SC
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Medical City Dallas Hospital
mi
from
Dallas, TX
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Medical City Dallas Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Click here to add this to my saved trials
Automated Tele Counseling for Screening Mammography
Automated Tele Counseling for Screening Mammography
Status: Enrolling
Updated:  2/19/2016
Boston Med Ctr
mi
from
Boston, MA
Automated Tele Counseling for Screening Mammography
Automated Tele Counseling for Screening Mammography
Status: Enrolling
Updated: 2/19/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Music Video and Adolescent/Young Adult Resilience During Transplant
Status: Enrolling
Updated:  2/19/2016
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus
mi
from
Atlanta, GA
Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Music Video and Adolescent/Young Adult Resilience During Transplant
Status: Enrolling
Updated: 2/19/2016
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus
mi
from
Atlanta, GA
Click here to add this to my saved trials
Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Music Video and Adolescent/Young Adult Resilience During Transplant
Status: Enrolling
Updated:  2/19/2016
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
St. Louis, MO
Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Music Video and Adolescent/Young Adult Resilience During Transplant
Status: Enrolling
Updated: 2/19/2016
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
St. Louis, MO
Click here to add this to my saved trials
Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Music Video and Adolescent/Young Adult Resilience During Transplant
Status: Enrolling
Updated:  2/19/2016
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Music Video and Adolescent/Young Adult Resilience During Transplant
Status: Enrolling
Updated: 2/19/2016
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
A Phase II Trial of Lapatinib and Capectiabine for Patients With Refractory Advanced Colorectal Adenocarcinoma (LAP109859)
Status: Enrolling
Updated:  2/19/2016
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
A Phase II Trial of Lapatinib and Capectiabine for Patients With Refractory Advanced Colorectal Adenocarcinoma (LAP109859)
Status: Enrolling
Updated: 2/19/2016
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer
LCI-GU-BLA-SPEC-001: Expression of the Aurora Kinase Family and Chemoresistance in Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  2/20/2016
Carolinas HealthCare System
mi
from
Charlotte, NC
LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer
LCI-GU-BLA-SPEC-001: Expression of the Aurora Kinase Family and Chemoresistance in Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 2/20/2016
Carolinas HealthCare System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
Open-Label Phase 1 Dose Escalation Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
Status: Enrolling
Updated:  2/20/2016
MUSC
mi
from
Charleston, SC
Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
Open-Label Phase 1 Dose Escalation Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
Status: Enrolling
Updated: 2/20/2016
MUSC
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors.
Status: Enrolling
Updated:  2/20/2016
Sarah Cannon Cancer Center
mi
from
Nashville, TN
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors.
Status: Enrolling
Updated: 2/20/2016
Sarah Cannon Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Storage of Bile From Routine Procedures to Study Risk Factors
A Prospective Study of Human Bile and Molecular Predictors of Biliary Malignancy Risk
Status: Enrolling
Updated:  2/22/2016
Indiana University Hospital
mi
from
Indianapolis, IN
Storage of Bile From Routine Procedures to Study Risk Factors
A Prospective Study of Human Bile and Molecular Predictors of Biliary Malignancy Risk
Status: Enrolling
Updated: 2/22/2016
Indiana University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer
Pilot Phase II Study of Metronomic Chemotherapy in Combination With Avastin in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/22/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer
Pilot Phase II Study of Metronomic Chemotherapy in Combination With Avastin in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/22/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
Phase I/IIa Study of the Novel Combination of Bendamustine With Irinotecan Followed by Etoposide/Carboplatin in Chemonaive Patients With Extensive Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  2/22/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
Phase I/IIa Study of the Novel Combination of Bendamustine With Irinotecan Followed by Etoposide/Carboplatin in Chemonaive Patients With Extensive Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 2/22/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
Phase I/IIa Study of the Novel Combination of Bendamustine With Irinotecan Followed by Etoposide/Carboplatin in Chemonaive Patients With Extensive Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  2/22/2016
Georgia Cancer Specialists
mi
from
Marietta, GA
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
Phase I/IIa Study of the Novel Combination of Bendamustine With Irinotecan Followed by Etoposide/Carboplatin in Chemonaive Patients With Extensive Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 2/22/2016
Georgia Cancer Specialists
mi
from
Marietta, GA
Click here to add this to my saved trials
Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
A Phase II Study of Amrubicin Chemotherapy as First Line Treatment in Patients With Metastatic or Unresectable Soft Tissue Sarcoma
Status: Enrolling
Updated:  2/22/2016
Santa Monica
mi
from
Santa Monica, CA
Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
A Phase II Study of Amrubicin Chemotherapy as First Line Treatment in Patients With Metastatic or Unresectable Soft Tissue Sarcoma
Status: Enrolling
Updated: 2/22/2016
Santa Monica
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
A Phase II Study of Amrubicin Chemotherapy as First Line Treatment in Patients With Metastatic or Unresectable Soft Tissue Sarcoma
Status: Enrolling
Updated:  2/22/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
A Phase II Study of Amrubicin Chemotherapy as First Line Treatment in Patients With Metastatic or Unresectable Soft Tissue Sarcoma
Status: Enrolling
Updated: 2/22/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Circulating Tumor Cells in Operative Blood
Circulating Tumor Cells Shed in Operative Blood During Pancreatectomy for Pancreatic Cancer is Responsible for Peritoneal Recurrence
Status: Enrolling
Updated:  2/22/2016
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Circulating Tumor Cells in Operative Blood
Circulating Tumor Cells Shed in Operative Blood During Pancreatectomy for Pancreatic Cancer is Responsible for Peritoneal Recurrence
Status: Enrolling
Updated: 2/22/2016
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Estimating the Global Need for Palliative Care for Children
Estimating the Global Need for Palliative Care for Children: A Cross Sectional Analysis
Status: Enrolling
Updated:  2/22/2016
International Children's Palliative Care Network
mi
from
Fairfax Station, VA
Estimating the Global Need for Palliative Care for Children
Estimating the Global Need for Palliative Care for Children: A Cross Sectional Analysis
Status: Enrolling
Updated: 2/22/2016
International Children's Palliative Care Network
mi
from
Fairfax Station, VA
Click here to add this to my saved trials
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
A Phase II Clinical Trail of the Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Previously Treated, Advanced NSCLC Patients With Wildtype Retinoblastoma Protein (RB) and Inactive Cyclin Dependent Kinase (CDK)N2a
Status: Enrolling
Updated:  2/23/2016
H. Lee Moffitt Cancer and Research Institute
mi
from
Tampa, FL
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
A Phase II Clinical Trail of the Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Previously Treated, Advanced NSCLC Patients With Wildtype Retinoblastoma Protein (RB) and Inactive Cyclin Dependent Kinase (CDK)N2a
Status: Enrolling
Updated: 2/23/2016
H. Lee Moffitt Cancer and Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
A Phase II Clinical Trail of the Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Previously Treated, Advanced NSCLC Patients With Wildtype Retinoblastoma Protein (RB) and Inactive Cyclin Dependent Kinase (CDK)N2a
Status: Enrolling
Updated:  2/23/2016
UF Health Cancer Center
mi
from
Gainesville, FL
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
A Phase II Clinical Trail of the Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Previously Treated, Advanced NSCLC Patients With Wildtype Retinoblastoma Protein (RB) and Inactive Cyclin Dependent Kinase (CDK)N2a
Status: Enrolling
Updated: 2/23/2016
UF Health Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
WCC# 59: Pilot Study of Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence
Status: Enrolling
Updated:  2/23/2016
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
WCC# 59: Pilot Study of Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence
Status: Enrolling
Updated: 2/23/2016
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
A Pilot Phase 2 Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Advanced Malignant Mesothelioma
Status: Enrolling
Updated:  2/23/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
A Pilot Phase 2 Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Advanced Malignant Mesothelioma
Status: Enrolling
Updated: 2/23/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
A Phase II Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
Status: Enrolling
Updated:  2/23/2016
Lalita Pandit, MD, Inc.
mi
from
Fountain Valley, CA
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
A Phase II Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
Status: Enrolling
Updated: 2/23/2016
Lalita Pandit, MD, Inc.
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer
A Phase 2 Study of ARQ 197 in Metastatic Triple-negative Breast Cancer
Status: Enrolling
Updated:  2/23/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer
A Phase 2 Study of ARQ 197 in Metastatic Triple-negative Breast Cancer
Status: Enrolling
Updated: 2/23/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer
A Phase 2 Study of ARQ 197 in Metastatic Triple-negative Breast Cancer
Status: Enrolling
Updated:  2/23/2016
Dana-Farber Cancer Institute at Faulkner Hospital
mi
from
Boston, MA
Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer
A Phase 2 Study of ARQ 197 in Metastatic Triple-negative Breast Cancer
Status: Enrolling
Updated: 2/23/2016
Dana-Farber Cancer Institute at Faulkner Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
A Phase 1, Open-Label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin (Thioureidobutyronitrile) Administered Intravenously, in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  2/23/2016
Dana-Farber / Beth Israel Deaconess Medical Center / Harvard Cancer Center
mi
from
Boston, MA
A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
A Phase 1, Open-Label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin (Thioureidobutyronitrile) Administered Intravenously, in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/23/2016
Dana-Farber / Beth Israel Deaconess Medical Center / Harvard Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated:  2/23/2016
Martel Eye Medical Group
mi
from
Rancho Cordova, CA
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated: 2/23/2016
Martel Eye Medical Group
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated:  2/23/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated: 2/23/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated:  2/23/2016
Infant Welfare Society of Chicago
mi
from
Chicago, IL
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated: 2/23/2016
Infant Welfare Society of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated:  2/23/2016
Outpatient Center in Lincoln Park
mi
from
Chicago, IL
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated: 2/23/2016
Outpatient Center in Lincoln Park
mi
from
Chicago, IL
Click here to add this to my saved trials
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated:  2/23/2016
Murray Pediatrics
mi
from
Murray, UT
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated: 2/23/2016
Murray Pediatrics
mi
from
Murray, UT
Click here to add this to my saved trials
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated:  2/23/2016
Daynes Eye and Lasik
mi
from
Salt Lake City, UT
PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients
Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis
Status: Enrolling
Updated: 2/23/2016
Daynes Eye and Lasik
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
Feasibility of Assessing Radiation Response With MRI/CT Directed Preoperative Accelerated Partial Breast Irradiation in the Prone Position for Hormone Responsive Early Stage Breast Cancer
Status: Enrolling
Updated:  2/23/2016
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
Feasibility of Assessing Radiation Response With MRI/CT Directed Preoperative Accelerated Partial Breast Irradiation in the Prone Position for Hormone Responsive Early Stage Breast Cancer
Status: Enrolling
Updated: 2/23/2016
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals
PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals
Status: Enrolling
Updated:  2/23/2016
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals
PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals
Status: Enrolling
Updated: 2/23/2016
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Status: Enrolling
Updated:  2/23/2016
University of Wisconsin Chemoprevention Consortium
mi
from
Madison, WI
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Status: Enrolling
Updated: 2/23/2016
University of Wisconsin Chemoprevention Consortium
mi
from
Madison, WI
Click here to add this to my saved trials
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Fairway, KA
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Fairway, KA
Click here to add this to my saved trials
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Cleveland, OH
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Dallas, TX
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction
Status: Enrolling
Updated:  2/24/2016
Clinical Research Facility
mi
from
Houston, TX
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction
A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction
Status: Enrolling
Updated: 2/24/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive
Status: Enrolling
Updated:  2/24/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive
Status: Enrolling
Updated: 2/24/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated:  2/24/2016
Kaiser Permanente - Deer Valley
mi
from
Antioch, CA
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated: 2/24/2016
Kaiser Permanente - Deer Valley
mi
from
Antioch, CA
Click here to add this to my saved trials
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated:  2/24/2016
Kaiser Permanente - Fremont
mi
from
Fremont, CA
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated: 2/24/2016
Kaiser Permanente - Fremont
mi
from
Fremont, CA
Click here to add this to my saved trials
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated:  2/24/2016
Kaiser Permanente Medical Center - Hayward
mi
from
Hayward, CA
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated: 2/24/2016
Kaiser Permanente Medical Center - Hayward
mi
from
Hayward, CA
Click here to add this to my saved trials
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated:  2/24/2016
Kaiser Permanente Medical Center - Oakland
mi
from
Oakland, CA
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated: 2/24/2016
Kaiser Permanente Medical Center - Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated:  2/24/2016
Kaiser Permanente Medical Center - Redwood City
mi
from
Redwood City, CA
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer
Status: Enrolling
Updated: 2/24/2016
Kaiser Permanente Medical Center - Redwood City
mi
from
Redwood City, CA
Click here to add this to my saved trials